Back
Fulcrum Therapeutics Vs. Entrada Therapeutics Industry Stock Comparison
Sell
40
FULC
Fulcrum Therapeutics
Last Price:
3.46
Seasonality Move:
85.55%
Buy
71
TRDA
Entrada Therapeutics
Last Price:
19.64
Seasonality Move:
-34.31%
Sell
40
Fulcrum Therapeutics (FULC)
is a Sell
Is Fulcrum Therapeutics a Buy, Sell or Hold?
- The current Fulcrum Therapeutics [FULC] share price is $3.44. The Score for FULC is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- FULC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Entrada Therapeutics (TRDA)
is a Buy
Is Entrada Therapeutics a Buy, Sell or Hold?
- The current Entrada Therapeutics [TRDA] share price is $18.65. The Score for TRDA is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- TRDA is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FULC Stock Price Chart
What is Fulcrum Therapeutics's stock price today?
-
The Fulcrum Therapeutics share price today is $3.44
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FULC is experiencing buying pressure, which is a positive indicator for future bullish movement.
TRDA Stock Price Chart
What is Entrada Therapeutics's stock price today?
-
The Entrada Therapeutics share price today is $18.65
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRDA is experiencing slight selling pressure.
FULC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.31 | Sell |
| Relative Strength Index (14 RSI): | 43.09 | Sell |
| Chaikin Money Flow: | 1011197 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.23 - 3.63) | Buy |
| Bollinger Bands (100): | (3.84 - 8.74) | Sell |
TRDA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.52 | Buy |
| Relative Strength Index (14 RSI): | 69.19 | Buy |
| Chaikin Money Flow: | -85770 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.48 - 17.82) | Buy |
| Bollinger Bands (100): | (14.76 - 17.24) | Buy |
FULC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.26 | Buy |
| 20-day SMA: | 3.36 | Buy |
| 50-day SMA: | 4.57 | Sell |
| 200-day SMA: | 7.42 | Sell |
| 8-day EMA: | 3.31 | Buy |
| 20-day EMA: | 3.46 | Sell |
| 50-day EMA: | 4.48 | Sell |
| 200-day EMA: | 6.32 | Sell |
TRDA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.71 | Buy |
| 20-day SMA: | 17.31 | Buy |
| 50-day SMA: | 16.28 | Buy |
| 200-day SMA: | 14.98 | Buy |
| 8-day EMA: | 17.87 | Buy |
| 20-day EMA: | 17.32 | Buy |
| 50-day EMA: | 16.63 | Buy |
| 200-day EMA: | 15.5 | Buy |
Fulcrum Therapeutics Earnings Growth & FULC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.41 per share, and a decrease next year of $0.78 per share.
Entrada Therapeutics Earnings Growth & TRDA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.04 per share, and a decrease next year of $3.93 per share.
Fulcrum Therapeutics Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Entrada Therapeutics Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||